These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35047120)

  • 21. Defects in GnRH Neuron Migration/Development and Hypothalamic-Pituitary Signaling Impact Clinical Variability of Kallmann Syndrome.
    Kałużna M; Budny B; Rabijewski M; Kałużny J; Dubiel A; Trofimiuk-Müldner M; Wrotkowska E; Hubalewska-Dydejczyk A; Ruchała M; Ziemnicka K
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34198905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel mutation in FGFR1 gene in patients with Kallmann syndrome by high throughput sequencing.
    Jin BF; Ji ZY; Su ZY; Mei LB; Huang XJ; Lin SB; Li P; Sha YW
    Syst Biol Reprod Med; 2018 Jun; 64(3):202-206. PubMed ID: 29658329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Microdeletion in the X Chromosome Leads to Kallmann Syndrome, Ichthyosis, Obesity, and Strabismus.
    Ma W; Mao J; Wang X; Duan L; Song Y; Lian X; Zheng J; Liu Z; Nie M; Wu X
    Front Genet; 2020; 11():596. PubMed ID: 32670353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted next generation sequencing approach identifies eighteen new candidate genes in normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Quaynor SD; Bosley ME; Duckworth CG; Porter KR; Kim SH; Kim HG; Chorich LP; Sullivan ME; Choi JH; Cameron RS; Layman LC
    Mol Cell Endocrinol; 2016 Dec; 437():86-96. PubMed ID: 27502037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.
    Stamou MI; Georgopoulos NA
    Metabolism; 2018 Sep; 86():124-134. PubMed ID: 29108899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone involvement in males with Kallmann disease.
    Iolascon G; Frizzi L; Bianco M; Gimigliano F; Palumbo V; Sinisi AM; Sinisi AA
    Aging Clin Exp Res; 2015 Oct; 27 Suppl 1():S31-6. PubMed ID: 26201943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical phenotype of a Kallmann syndrome patient with IL17RD and CPEB4 variants.
    Zhang J; Yang S; Zhang Y; Liu F; Hao L; Han L
    Front Endocrinol (Lausanne); 2024; 15():1343977. PubMed ID: 38628584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Acierno JS; Meysing A; Eliseenkova AV; Ma J; Ibrahimi OA; Metzger DL; Hayes FJ; Dwyer AA; Hughes VA; Yialamas M; Hall JE; Grant E; Mohammadi M; Crowley WF
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6281-6. PubMed ID: 16606836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCDC141 Mutations in Idiopathic Hypogonadotropic Hypogonadism.
    Turan I; Hutchins BI; Hacihamdioglu B; Kotan LD; Gurbuz F; Ulubay A; Mengen E; Yuksel B; Wray S; Topaloglu AK
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1816-1825. PubMed ID: 28324054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report: Novel SIN3A loss-of-function variant as causative for hypogonadotropic hypogonadism in Witteveen-Kolk syndrome.
    Correa Brito L; Keselman A; Villegas F; Scaglia P; Esnaola Azcoiti M; Castro S; Sanguineti N; Izquierdo A; Maier M; Bergadá I; Arberas C; Rey RA; Ropelato MG
    Front Genet; 2024; 15():1354715. PubMed ID: 38528912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central hypogonadism in Klinefelter syndrome: report of two cases and review of the literature.
    Cangiano B; Indirli R; Profka E; Castellano E; Goggi G; Vezzoli V; Mantovani G; Arosio M; Persani L; Borretta G; Ferrante E; Bonomi M
    J Endocrinol Invest; 2021 Mar; 44(3):459-470. PubMed ID: 32537678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland.
    Laitinen EM; Vaaralahti K; Tommiska J; Eklund E; Tervaniemi M; Valanne L; Raivio T
    Orphanet J Rare Dis; 2011 Jun; 6():41. PubMed ID: 21682876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Characteristics of Novel FGFR1 Mutations in Patients with Isolated Gonadotropin-Releasing Hormone Deficiency.
    Choi JH; Oh A; Lee Y; Kim GH; Yoo HW
    Exp Clin Endocrinol Diabetes; 2021 Jun; 129(6):457-463. PubMed ID: 32485746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clues to an early diagnosis of Kallmann syndrome.
    Kaplan JD; Bernstein JA; Kwan A; Hudgins L
    Am J Med Genet A; 2010 Nov; 152A(11):2796-801. PubMed ID: 20949504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
    Sarfati J; Dodé C; Young J
    Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compromised Volumetric Bone Density and Microarchitecture in Men With Congenital Hypogonadotropic Hypogonadism.
    Ostertag A; Papadakis GE; Collet C; Trabado S; Maione L; Pitteloud N; Bouligand J; De Vernejoul MC; Cohen-Solal M; Young J
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3312-e3326. PubMed ID: 33725720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.
    Jongmans MC; van Ravenswaaij-Arts CM; Pitteloud N; Ogata T; Sato N; Claahsen-van der Grinten HL; van der Donk K; Seminara S; Bergman JE; Brunner HG; Crowley WF; Hoefsloot LH
    Clin Genet; 2009 Jan; 75(1):65-71. PubMed ID: 19021638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parallel Multi-Gene Panel Testing for Diagnosis of Idiopathic Hypogonadotropic Hypogonadism/Kallmann Syndrome.
    Senthilraja M; Chapla A; Jebasingh FK; Naik D; Paul TV; Thomas N
    Case Rep Genet; 2019; 2019():4218514. PubMed ID: 31781422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible Kallmann syndrome: report of the first case with a KAL1 mutation and literature review.
    Ribeiro RS; Vieira TC; Abucham J
    Eur J Endocrinol; 2007 Mar; 156(3):285-90. PubMed ID: 17322486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling, Bioinformatic, and Functional Data on the Developing Olfactory/GnRH System Reveal Cellular and Molecular Pathways Essential for This Process and Potentially Relevant for the Kallmann Syndrome.
    Garaffo G; Provero P; Molineris I; Pinciroli P; Peano C; Battaglia C; Tomaiuolo D; Etzion T; Gothilf Y; Santoro M; Merlo GR
    Front Endocrinol (Lausanne); 2013; 4():203. PubMed ID: 24427155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.